美国社会对于紧急事后避孕药 B 计划药物一直存在着两种截然相反的观点:反对派认为避孕药未经医生处方的出售将扩大获得药物的可能性,从而导致青少年滥交和社会混乱;支持派则认为非处方许可让需要的人更容易获得 B 计划,这样美国能减少计划外怀孕。最近,美国食品和药物管理局(FDA)结束长达3年的争论,决定允许药房向18岁以上的女性出售 B 计划。 American society has always had two opposite views on the emergency after-contraceptive B plan drug: the opposition believes that the sale of contraceptives without a doctor’s prescription will increase the possibility of obtaining drugs, which will lead to promiscuity and social dislocation; It is considered that over-the-counter licensing makes it easier for people who need it to obtain Plan B so that the United States can reduce unplanned pregnancy. Recently, the US Food and Drug Administration (FDA) ended its three-year dispute and decided to allow pharmacies to sell the B plan to women over 18 years of age.